CHRISTOPHER JOHN MCGANN, MD
Osteopathic Medicine at 17 Ave, Seattle, WA

2010016, Jun 24, 2010

Dec 24, 2008

12/344164

Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US

A61B 5/055, A61B 5/02

600410, 600508

Certain embodiments of the invention provide methods of assessing a patient's risk for atrial fibrillation (AF) recurrence after receiving treatment with an AF treatment modality, that include determining, from left atrium (LA) tissue image data of a patient, a level of a parameter that is positively proportional to an amount of unhealthy tissue in a wall of the LA of the patient; and outputting, to an output device, an indicator of a comparison between (i) the determined level and (ii) a first threshold level of the parameter, the first threshold level derived from LA tissue image data of at least one other patient, who experienced an AF recurrence after treatment with the AF treatment modality. In certain embodiments, levels of the parameter equal to or greater than the first threshold level are indicative of a significant risk of AF recurrence after treatment with the AF treatment modality.

2010016, Jun 24, 2010

Dec 24, 2008

12/344169

Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US

A61B 5/055, A61B 6/00, A61B 5/02

600420, 600431, 600508, 600407

Certain embodiments provide a method of assessing an outcome of an ablative atrial fibrillation (AF) treatment modality administered to a patient, the method including: determining, from left atrium (LA) tissue image data of a subject patient that has undergone an ablative AF treatment with the modality, at least one of: a level of a parameter that is positively proportional or negatively proportional to an amount of ablated tissue in a wall of the LA of the subject patient; and a spatial distribution, in the LA wall, of a variable indicative of ablated LA tissue; and outputting, to an output device, a machine-readable indicator of at least one of: (i) a comparison between the determined level and a threshold level of the parameter; and (ii) a map of the spatial distribution.

2010029, Nov 25, 2010

May 20, 2010

12/784487

Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugueni Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
Marcos Daccarett - Salt Lake City UT, US

A61B 5/055, A61B 5/00, A61B 6/00

600420, 600300, 600431

Certain embodiments provide a method of assessing a risk of thromboembolic stroke in a patient. The method comprises acquiring image data and determining an indicator of a degree of fibrosis of a patient's left atrium (LA) based on the image data. The method also comprises estimating a level of risk of thromboembolic stroke of the patient based on the indicator.